Adherium Limited (ASX:ADR)
Australia · Delayed Price · Currency is AUD 0.0050
0.00 (0.00%)
Feb 9, 2026, 1:52 PM AEST
Adherium Company Description
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.
The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease.
It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution.
The company was founded in 2001 and is based in Melbourne, Australia.
Adherium Limited
| Country | Australia |
| Founded | 2001 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 40 |
| CEO | Dawn Bitz |
Contact Details
Address: 447 Collins Street Melbourne, VIC 3000 Australia | |
| Phone | 61 3 9415 4000 |
| Website | adherium.com |
Stock Details
| Ticker Symbol | ADR |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000ADR1 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dawn Bitz | Chief Executive Officer |
| Emily Austin | Company Secretary |
| Tom Quinlan | Caretaker Chief Financial Officer |
| Julie Quinlan | Head of People and Culture |
| Michael Motion | Consultant |
| David Haddad | Head of Product |
| Jason Hochman | Head of US Commercial/GTM |
| Hetal Dhruve | Head of Medical and Clinical Affairs |
| Catherine Morgan | Head of Regulatory and Quality |
| Dr. John Douglas Wilson ChB, FRACP, FRCPA, MB, Ph.D. | Executive Medical Director |